A novel and effective cancer immunotherapy mouse model using antigen-specific B cells selected in vitro.
Immunotherapies such as adoptive transfer of T cells or natural killer cells, or monoclonal antibody (MoAb) treatment have recently been recognized as effective means to treat cancer patients. However, adoptive transfer of B cells or plasma cells producing tumor-specific antibodies has not been appl...
Main Authors: | Tatsuya Moutai, Hideyuki Yamana, Takuya Nojima, Daisuke Kitamura |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3960256?pdf=render |
Similar Items
-
A novel cancer immunotherapy using tumor-infiltrating B cells in the APCmin/+ mouse model.
by: Xinying Wang, et al.
Published: (2021-01-01) -
T-cell cancer immunotherapy : characterisation and manipulation of tumour antigen-specific T cell subsets for adoptive immunotherapy in mouse models
by: White, Matthew
Published: (2011) -
Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases
by: Naomi Richardson, et al.
Published: (2020-07-01) -
Tumor-Associated Antigens for Specific Immunotherapy of Prostate Cancer
by: Marc Schmitz, et al.
Published: (2012-02-01) -
The role of peptide solubility in antigen-specific peptide immunotherapy
by: Shepard, Ella Ruth
Published: (2018)